A simplified method for following the urinary excretion of estriol, pregnanediol, and pregnanoloneduring the course of pregnancy is presented. The procedure has been used successfully in a large hospital laboratory. An important advantage is that the estrogen and progesterone metabolites are measured simultaneously, and separate extraction and gas-liquid chromatographyis not required.
HE CORRELATION
between urinary excretion of estrogens and fetal viability was first described in 1933 (1) . Since then, numerous articles confirming this observation have been published Similarly, a correlation between urinary pregiianediol and pregnanolone excretion, and the viability of pregnancy has been reported (9-13).
Other authors, however, state that pregnanediol and pregnanolone levels reflect placental function, but not necessarily fetal condition (9, 13). 
where d is the difference between the paired (N) results.
The following precision (1 S.D.) for tile measurements was attained; estriol, ±0.55 mg at the 15-30 mg/24 hr. level; pregnanediol, ± 1.28 mg at the 35-GO mg/24 hr. level; pregnanolone, ±0.31 mg at the 5-15 mg/ 24 hr. level.
To determine the recovery efficiency of the method, 0.1 mg each of the three steroids was added to 50 ml of "male" urine and run through 
